Journal article · 2026 · Open access

Artificial intelligence and machine learning in drug discovery and development: a comprehensive review

Krushna A. Chaudhari, Kedar Mathpati, Ashish Rajabhau Alte

Future Journal of Pharmaceutical Sciences, 12(1) · Published 26 June 2026 · DOI 10.1186/s43094-026-00997-6

Free PDFView at the publisherCite this paper

In brief

“Artificial intelligence and machine learning in drug discovery and development: a comprehensive review” is a 2026 journal article by Krushna A. Chaudhari and 2 co-authors, published in Future Journal of Pharmaceutical Sciences. OpenAlex counts 2 citations as of 15 November 2026, which puts it in the top 5% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Future Journal of Pharmaceutical Sciences.

Citations
2
Most cited in
2026 (2)
Field-weighted impact
3.18
References
14
Authors
3

Abstract

The drug discovery and development process is a complex, resource-intensive, and high-risk endeavour, traditionally characterized by long timelines, high costs, and low success rates. Recent advancements in artificial intelligence (AI) have transformed this landscape by enabling data-driven, predictive, and efficient strategies across the entire drug development pipeline. AI technologies, including machine learning (ML), deep learning (DL), and neural networks, have been employed for target identification, lead discovery, structure-based drug design, ADME/T prediction, toxicity assessment, and de novo molecule generation. AI-driven tools and platforms, such as DeepChem, AlphaFold, and IBM Watson, facilitate virtual screening, chemical space exploration, and patient-specific clinical trial optimization. Additionally, AI has revolutionized advanced applications in drug delivery, including nanorobotics and synergistic combination therapies, and has enhanced nanomedicine formulations for improved efficacy and safety. Despite its transformative potential, AI adoption faces challenges, including data scarcity, high costs, skill gaps, regulatory constraints, and the black box phenomenon. Nevertheless, with appropriate strategies, AI promises to accelerate drug discovery, reduce costs, improve success rates, and enable the development of safer and more effective therapeutics, marking a paradigm shift in pharmaceutical research and development.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Chaudhari, K. A., Mathpati, K., & Alte, A. R. (2026). Artificial intelligence and machine learning in drug discovery and development: a comprehensive review. Future Journal of Pharmaceutical Sciences, 12(1). https://doi.org/10.1186/s43094-026-00997-6

MLA 9

Chaudhari, Krushna A., et al. “Artificial intelligence and machine learning in drug discovery and development: a comprehensive review.” Future Journal of Pharmaceutical Sciences, vol. 12, no. 1, 2026. https://doi.org/10.1186/s43094-026-00997-6.

Chicago

Chaudhari, Krushna A., Kedar Mathpati, and Ashish Rajabhau Alte. 2026. “Artificial intelligence and machine learning in drug discovery and development: a comprehensive review.” Future Journal of Pharmaceutical Sciences 12 (1). https://doi.org/10.1186/s43094-026-00997-6.

Harvard

Chaudhari, K. A., Mathpati, K. and Alte, A. R. (2026) ‘Artificial intelligence and machine learning in drug discovery and development: a comprehensive review’, Future Journal of Pharmaceutical Sciences, 12(1). doi:10.1186/s43094-026-00997-6.

IEEE

K. A. Chaudhari, K. Mathpati, and A. R. Alte, “Artificial intelligence and machine learning in drug discovery and development: a comprehensive review,” Future Journal of Pharmaceutical Sciences, vol. 12, no. 1, 2026, doi: 10.1186/s43094-026-00997-6.

BibTeX

@article{chaudhari2026artificial,
  title     = {{Artificial intelligence and machine learning in drug discovery and development: a comprehensive review}},
  author    = {Chaudhari, Krushna A. and Mathpati, Kedar and Alte, Ashish Rajabhau},
  journal   = {Future Journal of Pharmaceutical Sciences},
  year      = {2026},
  volume    = {12},
  number    = {1},
  doi       = {10.1186/s43094-026-00997-6},
  url       = {https://doi.org/10.1186/s43094-026-00997-6}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • artificial intelligence in drug discovery
  • machine learning
  • deep learning
  • target identification
  • lead compound identification
  • structure-based drug design
  • ADMET prediction
  • toxicity prediction

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Chaudhari, K. A., Mathpati, K., & Alte, A. R. (2026). Artificial intelligence and machine learning in drug discovery and development: a comprehensive review. Future Journal of Pharmaceutical Sciences, 12(1). https://doi.org/10.1186/s43094-026-00997-6

How many times has this paper been cited?

2 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Future Journal of Pharmaceutical Sciences.

Who wrote this paper?

Krushna A. Chaudhari, Kedar Mathpati, Ashish Rajabhau Alte.

What is the DOI of this paper?

10.1186/s43094-026-00997-6. The permanent link is https://doi.org/10.1186/s43094-026-00997-6.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.